[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Avisi Technologies Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100609922",false,"NCT07220876","Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma","A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma","Inclusion Criteria:\n\n* Open angle, pseudoexfoliative or pigmentary glaucoma\n* IOP at preoperative visit of ≥ 20mmHg and ≤ 40mmHg\n* Visual field mean deviation score of -3dB or worse\n* Area of healthy, free and mobile conjunctiva in the target quadrant\n* Shaffer angle grade ≥ 2 in the target quadrant\n\nExclusion Criteria:\n\n* Angle closure glaucoma\n* Congenital, neovascular or other secondary glaucomas\n* Previous intraocular surgery, with the exception of uncomplicated cataract surgery\n* Previous glaucoma shunt\u002Fvalve in the target quadrant\n* Clinically significant inflammation or infection in the study eye within 30 days prior to the operative visit\n* History of corneal surgery, corneal opacities or corneal disease\n* Retinal or optic nerve disorders, either degenerative or evolutive, that are not associated with the existing glaucoma condition","ALL","45 Years",{"count":18,"type":19},165,"ESTIMATED","INTERVENTIONAL",[22],"NA","A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial",[25],"Open Angle Glaucoma (OAG)",[27],"Glaucoma","RECRUITING","2025-12-08",{"date":31,"type":32},"2025-12-15","ACTUAL",{"date":34,"type":32},"2025-11-07",{"date":36,"type":19},"2027-10",{"name":38,"class":39},"Avisi Technologies Inc.","INDUSTRY",12,""]